There is a variety of tumors affecting the pituitary gland in childhood; some of these
tumors (eg craniopharyngioma) are included among the most common central nervous system
tumors in childhood. The gene(s) involved in the pathogenesis of these tumors are largely
not known; their possible association with other developmental defects or inheritance
pattern(s) has not been investigated. The present study serves as a (i)
screening/training, and, (ii) a research protocol.
As a screening and training study, this protocol allows our Institute to admit children
with tumors of the hypothalamic-pituitary unit to the pediatric endocrine clinics and
wards of the NIH Clinical Center for the purposes of.(i)
Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms |
Yes |
Study Type
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes. Searching Both is inclusive of interventional and observational studies. |
Observational |
Eligible Ages | 3 Years - 70 Years |
Gender | All |
Trial ID:
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries. |
NCT00001595 |
Phase
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans. Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data. Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use. |
|
Lead Sponsor
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data. |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
Principal Investigator
The person who is responsible for the scientific and technical direction of the entire clinical study. |
Christina Tatsi, M.D. |
Principal Investigator Affiliation | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
Agency Class
Category of organization(s) involved as sponsor (and collaborator) supporting the trial. |
NIH |
Overall Status | Recruiting |
Countries | United States |
Conditions
The disease, disorder, syndrome, illness, or injury that is being studied. |
Panhypopituitarism, Gigantism/Acromegaly, Prolactinoma, Cushing Disease |
Study Website: | View Trial Website |
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.